{{Rsnum
|rsid=4359426
|Gene=CCL22
|Chromosome=16
|position=57358821
|Orientation=plus
|GMAF=0.07759
|Gene_s=CCL22
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 8.8 | 91.2
| HCB | 0.7 | 26.3 | 73.0
| JPT | 1.8 | 22.1 | 76.1
| YRI | 2.0 | 7.5 | 90.5
| ASW | 0.0 | 5.3 | 94.7
| CHB | 0.7 | 26.3 | 73.0
| CHD | 0.0 | 20.2 | 79.8
| GIH | 1.0 | 9.9 | 89.1
| LWK | 0.0 | 8.2 | 91.8
| MEX | 3.4 | 29.3 | 67.2
| MKK | 0.0 | 7.1 | 92.9
| TSI | 0.0 | 7.8 | 92.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=23268288
|Title=CCL22 16C/A Genetic Variation is not Associated with Breast Carcinoma in Southern Iranian Population
}}

{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}